The relative frequency of TP53 mutation at codon 249 was 11.1% (16 of 133 samples) in patients with pancreatic cancer compared to 3.5% (3 of 85 samples) in the group of control which was significant (P = 0.03). This evidence concerns the gene TP53 and familial pancreatic carcinoma.